ALAMEDA, Calif.--(BUSINESS WIRE)--AllCells, LLC, (the “company”) has long been recognized as a leading industry provider of hematologic tissue, primary cell products (healthy & diseased), and cell-based assay services (“Bioservices”) which support global life science research. The company today announced its expansion into therapeutic applications through the introduction of clinical grade products for further processing of allogeneic cell therapies. AllCells will initially introduce standard (and custom) pack sizes of Clinical Grade Fresh Whole Bone Marrow early 2016, followed by Clinical Grade Fresh Leuko Pak products.
